SBOTX Performance — Overlay B Portfolio, Class 2
Data updated: 2026-08-26
SBOTX returned +4.14% year to date and +9.28% over one year to Jun 2026. Annualised returns are +8.59% over 3 years and +2.61% over 5 years. The fund beat its Intermediate Core Bond category average: $100 invested three years ago grew to $128, against $115 for the category, and to $109 over one year, against $104. Volatility over the past three years was 7.29% a year. In the 12 months to Jun 2026 the fund lost a net $36.5M, and assets reached $288.75M.
SBOTX Growth of $100
What $100 invested in Overlay B Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Intermediate Core Bond category average over the same months.
| Period | SBOTX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $109 | $104 |
| 3 years (Jul 2023 – Jun 2026) | $128 | $115 |
| 5 years (Jul 2021 – Jun 2026) | $114 | $102 |
| Since data start (Jul 2019 – Jun 2026) | $132 | $112 |
SBOTX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +4.14% |
| 1 year | +9.28% |
| 3 years (annualised) | +8.59% |
| 5 years (annualised) | +2.61% |
SBOTX Annual Returns
Calendar-year total returns of Overlay B Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +4.14% |
| 2025 | +11.08% |
| 2024 | +5.93% |
| 2023 | +8.03% |
| 2022 | −16.13% |
| 2021 | +7.22% |
| 2020 | +8.27% |
| 2019 (Jul–Dec) | +2.72% |
SBOTX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.6% | +1.5% | −3.2% | +3.0% | +1.5% | −0.2% | — | — | — | — | — | — |
| 2025 | +1.4% | +1.1% | −1.4% | +1.1% | +1.1% | +2.5% | +0.1% | +1.9% | +1.7% | +1.0% | +0.3% | −0.2% |
| 2024 | −0.2% | +0.8% | +2.3% | −3.2% | +2.5% | +1.3% | +1.9% | +1.9% | +1.8% | −2.6% | +2.0% | −2.3% |
| 2023 | +3.9% | −2.8% | +2.5% | +0.4% | −1.7% | +1.1% | +1.4% | −1.6% | −3.4% | −2.0% | +5.8% | +4.6% |
| 2022 | −3.2% | −1.5% | −1.4% | −4.0% | −0.2% | −3.5% | +3.7% | −3.2% | −6.0% | +0.2% | +3.1% | −1.1% |
| 2021 | −0.4% | +0.2% | +1.1% | +2.1% | +0.8% | +0.8% | +1.4% | +0.7% | −2.1% | +1.6% | −0.5% | +1.4% |
| 2020 | +0.2% | −2.2% | −8.5% | +3.4% | +2.8% | +2.2% | +3.0% | +2.3% | −1.2% | −0.8% | +5.2% | +2.2% |
| 2019 | — | — | — | — | — | — | +0.1% | +0.6% | −0.3% | +0.6% | +0.4% | +1.1% |
SBOTX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 7.29%
- 3-year Sharpe ratio: 0.56 (vs 4.5% risk-free rate)
- Best month: +5.75% (Nov 2023)
- Worst month: −3.40% (Sep 2023)
SBOTX Fund Flows
Monthly money in and out of Overlay B Portfolio, from SEC Form N-PORT.
- 12-month net flow: −$36.5M
- 12-month gross sales (incl. reinvestments): $34.3M
- Sales ÷ redemptions: 0.48×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $735K | $5.8M | −$5.1M |
| May 2026 | $1.1M | $5.2M | −$4.1M |
| Apr 2026 | $8.0M | $10.0M | −$2.0M |
| Mar 2026 | $1.4M | $3.7M | −$2.3M |
| Feb 2026 | $3.3M | $6.6M | −$3.3M |
| Jan 2026 | $2.9M | $6.0M | −$3.1M |
| Dec 2025 | $10.7M | $5.3M | $5.3M |
| Nov 2025 | $1.3M | $6.9M | −$5.6M |
| Oct 2025 | $1.9M | $4.8M | −$2.9M |
| Sep 2025 | $810K | $3.4M | −$2.6M |
| Aug 2025 | $472K | $4.7M | −$4.3M |
| Jul 2025 | $1.7M | $8.2M | −$6.5M |
SBOTX Assets Under Management
Net assets of Overlay B Portfolio by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $288.75M |
| 2026-03-31 | $287.79M |
| 2025-12-31 | $297.02M |
| 2025-09-30 | $307.86M |
| 2025-06-30 | $309.78M |
| 2025-03-31 | $310.40M |
| 2024-12-31 | $351.76M |
| 2024-09-30 | $386.60M |
| 2024-06-30 | $375.89M |
| 2024-03-31 | $391.62M |
| 2023-12-31 | $540.19M |
| 2023-09-30 | $562.61M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.